Burzotta, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 21.926
AS - Asia 20.797
EU - Europa 17.157
SA - Sud America 4.119
AF - Africa 524
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 42
Totale 64.637
Nazione #
US - Stati Uniti d'America 21.234
SG - Singapore 10.358
DE - Germania 4.896
CN - Cina 4.424
BR - Brasile 3.373
SE - Svezia 2.634
IT - Italia 2.146
VN - Vietnam 1.915
FR - Francia 1.858
RU - Federazione Russa 1.310
IE - Irlanda 860
UA - Ucraina 846
GB - Regno Unito 836
JP - Giappone 668
ID - Indonesia 665
IN - India 545
FI - Finlandia 544
HK - Hong Kong 492
CA - Canada 313
AR - Argentina 291
TR - Turchia 259
BD - Bangladesh 255
PL - Polonia 248
MX - Messico 225
NL - Olanda 223
IQ - Iraq 222
KR - Corea 198
AT - Austria 162
ZA - Sudafrica 153
ES - Italia 126
BE - Belgio 99
EC - Ecuador 99
PK - Pakistan 89
CO - Colombia 84
SA - Arabia Saudita 83
VE - Venezuela 83
MA - Marocco 77
IR - Iran 66
EG - Egitto 62
JO - Giordania 60
UZ - Uzbekistan 59
LT - Lituania 58
AU - Australia 55
CL - Cile 51
KE - Kenya 48
PY - Paraguay 46
IL - Israele 45
PE - Perù 43
AE - Emirati Arabi Uniti 42
TN - Tunisia 41
DZ - Algeria 40
PH - Filippine 40
CH - Svizzera 39
JM - Giamaica 36
AZ - Azerbaigian 33
KZ - Kazakistan 32
EU - Europa 29
BY - Bielorussia 26
NP - Nepal 26
CZ - Repubblica Ceca 25
BO - Bolivia 23
GR - Grecia 23
HN - Honduras 23
PA - Panama 22
UY - Uruguay 22
BG - Bulgaria 21
KG - Kirghizistan 20
MY - Malesia 20
RO - Romania 20
CR - Costa Rica 18
ET - Etiopia 18
HU - Ungheria 18
LB - Libano 18
TH - Thailandia 17
AL - Albania 16
CI - Costa d'Avorio 16
DO - Repubblica Dominicana 16
LV - Lettonia 16
NZ - Nuova Zelanda 16
OM - Oman 16
KW - Kuwait 14
PT - Portogallo 14
TW - Taiwan 14
DK - Danimarca 13
PS - Palestinian Territory 13
SN - Senegal 13
QA - Qatar 12
MD - Moldavia 11
NO - Norvegia 11
RS - Serbia 11
BH - Bahrain 10
CG - Congo 10
HR - Croazia 10
NG - Nigeria 10
TT - Trinidad e Tobago 10
AM - Armenia 9
KH - Cambogia 9
SK - Slovacchia (Repubblica Slovacca) 9
AO - Angola 8
CY - Cipro 8
Totale 64.493
Città #
Singapore 5.663
Chandler 3.059
San Jose 2.812
Ashburn 2.233
Moscow 1.105
Beijing 916
Dublin 837
New York 747
Ho Chi Minh City 649
San Mateo 635
Hefei 620
Lauterbourg 613
Tokyo 605
Jakarta 583
Los Angeles 536
Hanoi 499
Rome 483
Jacksonville 416
Hong Kong 387
Wilmington 379
Frankfurt am Main 365
St Louis 364
Milan 349
Munich 347
Boston 336
The Dalles 310
Marseille 309
Nanjing 282
São Paulo 274
Princeton 273
Nürnberg 250
Helsinki 218
Dallas 215
Ann Arbor 206
Woodbridge 200
Kent 184
Santa Clara 184
Seattle 182
Seoul 174
Cattolica 155
Nuremberg 155
Chicago 148
Redwood City 147
Houston 144
Warsaw 138
Buffalo 135
Lawrence 134
Dearborn 131
Paris 126
Orem 115
Nanchang 114
Rio de Janeiro 112
Fairfield 110
London 107
Lancaster 106
Turku 105
Montreal 103
Bremen 102
Shanghai 101
Brooklyn 99
Atlanta 90
Brussels 90
Da Nang 90
Amsterdam 86
Baghdad 86
Vienna 85
Johannesburg 83
Haiphong 82
Izmir 82
Chennai 79
Düsseldorf 79
Hangzhou 79
Stockholm 77
Belo Horizonte 75
Denver 74
Lappeenranta 72
Norwalk 68
Phoenix 67
Council Bluffs 66
Mexico City 65
San Francisco 63
Tianjin 61
Toronto 61
Mountain View 59
Hebei 58
Ankara 56
Detroit 56
Amman 55
Brasília 55
Leawood 55
Guangzhou 54
Kraków 54
Manchester 54
Curitiba 53
Dhaka 53
Tashkent 52
Salvador 51
Zhengzhou 51
Boardman 50
Shenyang 49
Totale 34.061
Nome #
Rapid-deployment or transcatheter aortic valves in intermediate-risk patients? 877
How to solve difficult side branch access? 322
Impact of operator experience and wiring technique on procedural efficacy of trans-radial percutaneous chronic total occlusion recanalization performed by dedicated radialists 300
Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registry 282
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 271
Management of the access site after transradial percutaneous procedures: literature overview 266
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 259
Clinical and procedural impact of aortic arch anatomic variants in carotid stenting procedures 257
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 249
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 245
Renal artery stenting in patients with chronic ischemic heart disease 242
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 240
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 238
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 235
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 233
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 225
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 220
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 216
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 211
Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes 209
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 207
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 207
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 198
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 197
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 196
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 196
Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial 190
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 189
Ximelagatran/melagatran against conventional anticoagulation: A meta-analysis based on 22,639 patients 188
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 188
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 185
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 184
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 180
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 178
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 178
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 178
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 178
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 174
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 174
Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial 172
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 170
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 169
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 169
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 169
Myocardial bridge evaluation towards personalized medicine: study design and preliminary results of the RIALTO registry 168
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 168
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 168
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 167
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 167
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 165
Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions 165
Anatomical Annulus Predictors of New Permanent Pacemaker Implantation Risk after Balloon-expandable Trans-catheter Aortic Valve Implantation 164
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 164
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications 164
Reduced performance of Troponin T for acute coronary syndromes diagnosis in the elderly and very elderly patients: a retrospective study of 2688 patients 162
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 161
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials 160
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 160
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 160
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 160
Ethanol abolishes ischemic preconditioning in humans 159
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 159
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 159
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 159
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 159
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 158
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 157
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 157
Usefulness of EuroSCORE systems for risk stratification 157
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 157
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 153
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 151
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries 151
Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease : A Systematic Review and Meta-analysis 150
Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club 150
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 150
Angiographic assessment of microvascular perfusion--myocardial blush in clinical practice 149
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 149
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 148
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions 148
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 147
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 147
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 146
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 146
Heart valve critical pathway and heart valve clinic: novel benchmarks for modern management of valvular heart disease 146
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 145
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 145
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 144
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare 144
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 143
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study 142
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 142
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 141
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 140
Patients with in-stent restenosis have an increased risk of mid-term venous graft failure. 140
Results of Emergency Postoperative Re-Angiography After Cardiac Surgery Procedures 140
Impact of accuracy of fractional flow reserve to reduction of microvascular resistance after intracoronary adenosine in patients with angina pectoris or non-ST-segment elevation myocardial infarction 139
Safety and feasibility of iliac endovascular interventions with a radial approach. Results from a multicenter study coordinated by the Italian Radial Force 138
Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance 137
Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial 137
Totale 18.563
Categoria #
all - tutte 274.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 274.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021391 0 0 0 0 0 0 0 0 0 0 310 81
2021/20223.629 304 200 62 232 225 97 69 629 150 220 665 776
2022/20237.989 1.018 1.110 665 1.181 422 1.074 397 649 959 139 234 141
2023/20245.728 173 1.337 158 205 202 732 294 161 265 892 656 653
2024/202511.259 254 339 764 460 846 391 370 546 1.894 1.000 2.517 1.878
2025/202627.526 4.321 941 1.798 3.207 4.660 1.535 5.071 1.496 2.021 2.233 243 0
Totale 65.692